Epistaxis in Pregnant Women in the Covid-19 Era.

Introduction: Epistaxis is common throughout pregnancy and is usually not a cause for concern; severe nosebleeds are rare. An increased rate of nasal bleeding was observed during the COVID-19 epidemic.

Materials and methods: The study sample comprised 3,362 pregnant women who sought care at the Gynecologic and Obstetrics Department/ Al-Yarmouk Teaching Hospital and Al-Karkh Maternity Hospital between May 2020 and April 2021. All were asked to fill out a questionnaire.

Results: Nine hundred forty-one pregnant women experienced an episode of epistaxis during the last pregnancy. One thousand seven hundred forty-eight pregnant women had a corona-positive history. Pregnant women with a positive history of coronavirus infection have a higher incidence of epistaxis (612 pregnant women) than pregnant women with a corona-negative history (329 pregnant women) P value (0.039%).

Conclusions: Oxygen and blood-thinning drugs are the leading causes of the increased rate of nosebleeds among pregnant women during the Corona pandemic.